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The neurocysticercosis project in
Atteridgeville - Mamelodi townships
N. A. MAFOJANE
Abstract The incidence and prevalence of neurocysticerco-
sis in South Africa are unknown. A hospital-based
prospective study to deternrine the incidence of
neurocysticercosis was therefore undertaken. A
research questionnaire and strict inclusion and
exclusion criteria were used. Apart frOIn deter-
mining the incidence, our other aims were to
determine the sources of infection and routes of
transmission, evaluate therapeutic programmes
and, on the basis of our findings, develop preven-
tion programmes.
We found that it was impossible to determine
the sources of infection and routes of transmis-
sion. When strict selection criteria were applied
the number of patients (13) was significantly
smaller than the 58 patients in an earlier pilot pro-
ject. The implications of the findings for incidence
surveys are discussed.
The iInplications of the enzyme-linked
immunosorbent assay (EUSA) ofserum and cere-
brospinal fluid for diagnosis are discussed. The
effectiveness of praziquantel was confirmed, and
therapeutic approaches and preventive measures
based on our findings are suggested.
S AIr Med J 1994; 84: 208-211.
F ollowing a pilot neurocysticercosis projectconducted by our Neurology Department inAtteridgeville and Mamelodi townships, we de-
cided to undertake a full project to study the problem.
Kalafong Hospital is situated in Atteridgeville and pro-
vides all the inpatient care for the Atteridgeville and
Mamelodi suburban areas of Pretoria. The total popula-
tion of the two areas was 233 260 according to the 1980
census. The objectives of our full project were: (1) a
prospective study to determine the incidence of neuro-
cysticercosis in Atteridgeville - Mamelodi townships;
(il) to determine the sources of infection and routes of
transmission; (iil) to evaluate the effectiveness of thera-
peutic programmes; and (iv) to develop the basis for
prevention programmes.
We felt that the results of the project might con-
tribute to the debate raised in Campbell's' editorial,
'Another sinister silent epidemic?', in which a plea was
made for efforts to determine how great a problem
neurocysticercosis was and how best to prevent it.
The incubation period, i.e. the period between the
lodgement of oncospheres and the development of
symptoms, is said to average 4 - 5 years with a range of
1 year to 30 years. 2 This influenced our choice in respect
of the minimum period of residence in the two town-
ships necessary for inclusion in our project.
We believe that the design of prevention programmes
depends on accurate determination of the sources of
infection, modes of transmission and the magnitude of
Department of Neurology, Kalafong Hospital and University of
Pretoria
. A. MAFOJMTE, M.B. CH. B., F.C.P. (pAED.),
F.C.P. (NEURaL.) (SA)
Accepted 8 Nov 1993.
the problem. These considerations therefore also influ-
enced the design of our project.
Patients and methods
Patients
Index case finding entailed monitoring of the computed
tomographic (CT) brain-scans of symptomatic patients
at Kalafong Hospital. The scans were accepted for the
project if they satisfied the criteria laid down by Sotelo
et al. 3 for the diagnosis of neurocysticercosis.
Active disease is characterised by arachnoiditis,
hydrocephalus secondary to meninge.al inflammation,
parenchymal cysts, brain infarction secondary to vascu-
litis, mass effect due to a large cyst or clumps of cysts,
intraventricular cysts and spinal cysts.
Inactive disease is characterised by parenchymal cal-
cifications and hydrocephalus secondary to meningeal
fibrosis. For the purposes of our study the following CT
patterns were regarded as indicative of active neuro-
cysticercosis: (z) rounded areas of low density that were
not enhanced by the administration of contrast medium
(viable cysticerci); (il) hypodense or isodense lesions
surrounded by oedema and ring-like or nodular en-
hancement after the administration of contrast medium
(acute encephalitic phase of parenchymal neurocysticer-
cosis); and (iiz) diffuse brain swelling associated with
small lateral ventricles and multiple nodular ring-like
areas of enhancement after the administration of con-
trast medium (cysticercotic encephalitis).
The following were then done for each patient: (1) a
full history was taken; (iz) a full clinical examination was
done; (iil) a research questionnaire was completed;
(iv) enzyme-linked immunosorbent assays (ELISAs)
(immunoglobulin G (IgG)) of the serum and cerebro-
spinal fluid (CSF) were performed. This was done on .
the basis of Rosas er al.'s' statement that the diagnosis
of neurocysticercosis can only be conclusive with the aid
of CT and CSF analysis; (v) stools were examined for
parasites and eggs; and (viz) routine laboratory investi-
gations were undertaken, including assessment of CSF
pressure, microscopy, chemistry, culture and sensitivity;
full blood count with differential count and measure-
ment of erythrocyte sedinientation rate; serum micro-
analysis IT, serum glucose assessment, serum tests for
syphilis and tests for syphilis in CSF where indicated;
and urinalysis. Other tests, e.g. biopsy, were done where
indicated, as were tests for collagen disease and malig-
nancy.
The research questionnaire
The research questionnaire was designed to include
patients born or permanendy resident in Atteridgeville
or Mamelodi townships for a period of at least 18
months. This was to accommodate the shortest incuba-
tion period. It aimed to establish whether the sources of
their meat/food were solely the Atteridgeville/
Mamelodi/Pretoria municipal areas, and whether herbal
medication from traditional doctors (witch-doctors) was
a possible source of infection. In addition, it set out to
determine whether the infection originated within the
family, whether the patients ate pork, and whether their
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cooking or roasting of meat was thorough and how their
vegetables were prepared.
TABLE 11.
Pre-treatment CT scans and results of treatment
Patient Pre-treatment CT scans Results
Active' and inactive! Completely healed
with calcifications
2 Active and inactive Completely healed
with calcifications
3 Active and inactive Completely healed with
resorption of cysts
4 Active and inactive
5 Active and inactive
6 Active and inactive Hydrocephalus remitted
spontaneously
7 Inactive Healing with
calcifications
8 Active and inactive Healing with involution
and calcifications




11 Inactive Still awaiting repeat CT
12 Active and inactive Healing with involution
and calcifications
13 Active and inactive Healing with involution
and calcifications
TreatInent
All patients whose CT scans showed active disease were
treated for 14 days with oral praziquantel (pyrazino-iso-
quinolone) at 50 mg/kg body-weight/day, divided into
three equal doses. Symptomatic treannem, such as anti-
convulsants, steroids, mannitol, the shunting of CSF
and other surgical procedures were given as required.
Repeat eT scans were done after completion of the ini-
tial course of praziquantel treannenr. The reason for the
early repeat CT was to avoid defaulting and extra
expenditure.
Results (Table I)
The clinical features and results of the EUSAs on blood
and CSF are shov.'I1 in Table 1. The pre-treannent CT
scans and the results of treatment are sho\\'I1 in Table IT.
The ages of the patients ranged from 10 years to 55
years with an average of 32,8 years. Nine (69,2%) of the
patients presented with epilepsy, 2 (15,4%) with psychi-
atric disorders, 1 (7,7%) with headache and 1 (7,7%)
with headache followed by stupor. Ten (76,9%) patients
had active neurocysticercosis (viable cysticerci and/or
the acute encephalitic phase of parenchymal neuro-
cysticercosis) on their CT scans and 3 (23,1 %) inactive . Cysts, meningitis/arachnoiditis and their complications.
disease. _t_Ca_lc_if_ica_ti_on_s_. _
TABLE I.
Clinical data and ELlSA results
Age (yrs)/ Clinical ELlSA
Patient sex presentation Blood CSF
49/M Epilepsy High Mid-range
positive positive
2 28/M Epilepsy Low Mid-range
positive positive
3 25/M Epilepsy Low Low
positive positive
4 22/F Epilepsy Low Negative
positive
5 38/M Headache Low Negative
positive
6 38/M Headache Mid-range Mid-range
and stupor positive positive
7 10/M Epilepsy Mid-range Negative
positive
8 40/M Disorien- Low Negative
tation positive
9 43/F Epilepsy High High
positive positive
10 28/F Psychiatric Low Negative
disorder positive
11 20/M Epilepsy
12 55/M Epilepsy High
positive"
13 30/F Epilepsy High Low
positive positive
As shown in Tables I and IT, the EUSA in serum'
was positive in all 11 patients with neurocysticercosis.
The degree of positiviry ranged from low to high. In the
patient with inactive disease in whom the assay was
done, it was mid-range positive.
Of the 10 patients with active disease on whom
EUSAs of the CSF were done, 7 (70%) were positive
and 3 (30%) negative. In both patients with inactive
disease, the results were negative.'
Stool examination was negative for parasites or eggs
(ova) in all patients. All other special examinations had
normal results except for a biopsy of a subcutaneous
nodule in patient 1 which revealed cysticercosis.
The results of the questionnaire showed that the fol-
lowing possible sources of irtfection - traditional doc-
tors,' private slaughter, inadequate cooking or boiling
and family spread - were not confirmed by the
answers, and that the difficulty in pinpointing the
sources of irtfection was illustrated by the many points at
which infection could have taken place, outside and
inside the Pretoria/Aneridgeville/Mamelodi areas.
Results of treatInent (Table II)
For'reasons beyond our control the time interval from
completion of treatment to repeat CT ranged from 1
day to 4112 months. As shown in Table IT, all patients
with active neurocysticercosis on whom repeat CT was
performed, showed healing; cysts were either in various
stages of involution, or being replaced with calcifica-
tions. Patient 2 had his repeat scan 2 months after his
first and 34 days after completing his course of prazi-
quantel. As sho\\'I1 in Figs 1 and 2 the cysts have disap-
peared and one has been replaced by calcifications. Only
patient 10 needed a vemriculoperitoneal shunt. In
patient I, active neurocysticercosis had been present for
about 8 years. His lesions resolved prompdy on treat-
ment with praziquantel.
Patient 6 presented with headache and then gradu-
ally developed stupor which, on CT, proved to be due
to hydrocephalus involving mainly the lateral and third
ventricles. The clinical state improved and reversed
within 48 hours. Repeat CT showed that the hydro-
cephalus had resolved spontaneously. As the ELISAs
were mid-range positive in both the serum and CSF, the
patient was given full specific treannent.
FIG. 1
Discussion
Effectiveness of therapeutic programmes
As shown by our results, all patients with active neuro-
cysticercosis whose CT scans were repeated underwent
healing of the cysts following treatment with praziquan-
te!. The effectiveness of praziquantel has been demon-
strated on innumerable occasions since its first reported
successful use by Robles et al.' in 1979.
The disease can remain active for many years as in
patient 1 and during this period may spread to the CSF
pathwayslO and spinal cord." Prompt and full treatment
will prevent this. Although stools in all patients were
negative, up to 53% of patients with cysticercosis have
been reported to have intestinal taeniasis. II As these
patients are an epidemiologically important link in the
transmission chain of cysticercosis, their treatment is of
paramount importance. Epilepsy was the commonest
presenting clinical feature in our patients as in most
series of neurocysticercosis patients. It is believed that
early and adequate treatment with praziquantel rriay
prevent permanent epilepsy. I
Sources of infection and routes of trans-
mission
As mentioned in the results, all the patients had been in
and out of their areas of residence on innumerable occa-
sions; this makes pin-pointing of the sources of infection
impossible.
Incidence of neurocysticercosis in the
areas
The 13 patients, out of a population of 233 260, repre-
sent an incidence of 0,0557/1 000 population. For
economic, social and other reasons the census figures
are not accurate and consequently the incidence can, at
best, be regarded only as a rough estimate.
The basis for prevention programmes
Prevention programmes have to take the triad of agent
(parasite), host and environmental conditions into con-
sideration. Ingestion of food contaminated with ova is
believed to be the most common cause of neurocysticer-
cosis.I2 Eggs may stay alive in grasslands for as long as 8
months and in sewerage for 2 weeks although exposure
to desiccation kills them rapidly. I3 Whether praziquantel
is ovicidal for Taenia solium and other cestode eggs has
not been clearly established in man. I3 The patient har-
bouring the adult worm is more dangerous than the
FIG. 2
infected pig because he passes eggs in his stools. To
break the chain of neurocysticercosis infection, he
should be given full specific treatment. The one possible
exception to treatment is in the case of patien~ with the
encephalitic form of neurocysticercosis. 10
It has been recommended that mass diagnosis of the
population and treatment of all infected persons will
break the chain of transmission. I3 Whether our country
has sufficient manpower and can bear the cost of such a
project are doubtful. Given the problem of pin-pointing
the sources of infection, the following preventive mea-
sures should be given serious consideration.
Educational programmes on television, radio, in
newspapers and other media have the following aims: to
teach the public about the disease: its cause, sources of
infection, routes of transmission and its prevention.
Basic hygiene and thorough cooking and roasting of
pork and vegetables are emphasised. 14
Present public measures should be continued and
intensified to make sure that infected meat with viable
cysticerci does not reach the consumer. According to
the meat-board, light to moderately infected pork was
kept at -20°C for 3 days to kill the cysts. This has been
found to be effective elsewhere. I4 Heavily infected car-
casses were condemned and destroyed.
Other public health measures should include: (l) pre- .
vention of the use of night soil as a fertiliser; (il) provi-
sion of sanitary facilities; and (iil) adequate treatment of
sewerage to prevent infection ofpigs and cattle. I3
It is hoped that the above measures will help to
reduce the spread of the 'sinister silent epidemic'.
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REVIEW ARTICLE
Schistosomiasis and malignancy
L. B. LEMMER, P.J. FRIPP
Abstract It is generally accepted t.~at schistosomiasis, if not
causative, is at least associated with malignancy.
In this review, the epidemiology of schistosomiasis
and bladder carcinoma, as well as the role of
chronic bladder infection, are discussed together
with known carcinogenic factors, possible abnor-
mal vitamin metabolism and/or deficiencies and
factors that influence conjugated carcinogens.
Experimental evidence is briefly examined and
recent work from the Far East on schistosomiasis
and colon carcinoma reviewed.
SAfrMedJ1994; 84: 211-215.
I t has been estimated that over 250 million people inthe tropical and subtropical regions of the world suf-fer from schistosomiasis, also known as bilharziasis.
The parasitic disease rriay cause morbidity that is pro-
tean in character, and have a monality rate which is
difficult, if not impossible, to calculate, especially in
Third-World countries.
Of three major species of human schistosomes,
Schiswsoma japonicum is restricted to the Far East while
S. haemawbium is almost entirely restricted to the
African continent and parts of Asia Minor and the
Arabian peninsula. S. mansoni is found in Africa and
tropical pans of the Western hemisphere.
Apan from the granulomatous reaction to the eggs,
with its unique complications that may be seen in
almost any organ, a causal relationship between parasitic
infection and malignancy has been suggested. This asso-
ciation is more clearly defined in S. haemawbium infec-
tion (the causative agent of urinary or bladder schistoso-
miasis) than in S. mansoni or S. japonuum, which gener-
ally inhabit the ponal tract and involve the intestines
and lungs.
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Bladder carcinoma
Historical background
Theodor Bilharz first found adult worms of the trema-
tode, now known as S. haemawbium, in the ponal veins
of a cadaver in Cairo in 1851.' As early as 1905,
GoebeF noted the geographical similarity between
endemic S. haemacobium infection and the incidence of
bladder carcinoma, later to be supponed by Hashem'
(1961), Gillman and Prates' (1962), Prates and Torres'
(1965) and Brand" (1979), among others.
In 1911, Ferguson postulated a causal relationship
between the parasite and bladder carcinoma.7 Proof of
this association has remained somewhat elusive, with
proponents both for and against the argument; the laner
perhaps are in the minority, especially in recent years
when possible interactions between the parasite and uri-
nary carcinogens have become known.
Schistosomal epidemiology and the inci-
dence ofbladder carcinoma
In populations nor at risk for schistosomiasis, the peak
incidence of bladder carcinoma occurs during the 6th
decade of life; only 12% of cases occur in people under
the age of 50 years.' In lower Egypt, a hyper-endemic
region for S. haemawbium, the mean age of patients with
carcinoma of the bladder is 46 years; however, with
73% of patients below the age of 50 years.'o
The mean age of presentation with carcinoma of the
bladder in those areas of Malawi endemic for S. haema-
wbium is also lower (44,9 years) than in non-endemic
areas;" similar panems are seen in Zambia12 where most
of the patients were younger than 50 years.
Studies from Iraq based on the records of the
Baghdad Tumour Registry for the years 1976 - 1982
confirmed bladder carcinoma as the second most com-
mon malignancy recorded. The phenomenon was more
prominent in areas endemic for urinary schistosomiasis
where an even higher incidence was reponed. These
areas border Kuwait, where bladder carcinoma is the
third most common malignant tumour reported in
men." It has further been shown that carcinoma of the
bladder is the commonest malignancy seen in Egypt
with prevalence rates varying between 11 % and
40%.'0,14,15
